tiprankstipranks
Trending News
More News >
AN2 Therapeutics, Inc. (ANTX)
NASDAQ:ANTX
US Market

AN2 Therapeutics, Inc. (ANTX) Cash flow

Compare
105 Followers

AN2 Therapeutics, Inc. Cash Flow

ANTX's free cash flow for Q4 2025 was $-5.24M. For the 2025 fiscal year, ANTX's free cash flow was decreased by $19.42M and operating cash flow was $-5.24M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Investing Cash Flow
$ 28.31M$ 54.59M$ -43.28M$ -21.77M$ -50.02M
Financing Cash Flow
$ 113.00K$ 372.00K$ 84.99M$ 70.36M$ 78.53M
End Cash Position
$ 19.94M$ 21.35M$ 15.65M$ 27.22M$ 12.10M
Free Cash Flow
$ -29.83M$ -49.26M$ -53.29M$ -33.46M$ -20.48M
Currency in USD

AN2 Therapeutics, Inc. Cash Flow